期刊文献+

尼莫地平固体自微乳化舌下速溶片的制备及质量评价 被引量:8

Preparation and quality evaluation of nimodipine solid self-microemulsifying fast-disintegrating sublingual tablets
原文传递
导出
摘要 目的:制备尼莫地平固体自微乳化舌下速溶片(NM-S-SMFDST)并进行质量评价。方法:以最大饱和量,口感为指标筛选固体吸附载体的种类,考察其对尼莫地平固体自微乳化粉末流动性及溶出度的影响来确定吸附载体的量;以正交设计方法优化自微乳化舌下速溶片处方,并对外观、乳化后粒径及形态、崩解及润湿时间、含量均匀度、含量、溶出度及口感进行了评价。结果:优化最佳处方比例为:尼莫地平∶自乳化辅料混合物∶Aerosil-300∶甘露醇∶MCC∶PVPP∶阿斯巴甜=3.3%∶37.0%∶28.3%∶12.4%∶8%∶8%∶3%。所制备的NM-S-SMFDST外观及口感良好,乳化后粒径为:(34.4±2.62)nm,1 h累积溶出度达90%以上,崩解、湿润时限、含量以及含量均匀度达到要求。结论:所制得的NM-S-SMFDST处方及工艺合理,质量指标均符合舌下片的要求。 OBJECTIVE To prepare nimodipine solid self-microemulsifying fast disintegrating sublingual tablets and evaluate their quality. METHODS The type of adsorbents were screened with the maximum saturation and taste as index, and the capacity of adsorbents were determined by investigating the influence of adsorbents on nimodipine solid self-microemulsifying powder flowability and dissolution. The prescription was optimized by orthogonal test. The appearance, the particle size and morphology after emulsification, the disintegration and wetting time, the content uniformity, the content, the dissolution and the taste were evaluated. RESULTS The obtained best prescription was 3.3% of nimodipine, 37% of SMEDDS, 28.3% of Aerosil-300, 12. 4 % of mannitol, 8 % of MCC, 8 % of PVPP, 3 % of aspartame. NM-S-SMFDSTs were integrated with desira- ble appearance and taste. The particle size was (34. 4± 2. 62) nm, the cumulative dissolution percentage was above 90% within 1 h. The disintegration and wetting time, the content and content uniformity were up to requirement. CONCLUSION The prescription and technology are reasonable and the quality indexes conform to the requirement of NM-S-SMFDST.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第13期1079-1083,共5页 Chinese Journal of Hospital Pharmacy
关键词 尼莫地平 固体自微乳化舌下速溶片 正交设计 质量评价 nimodipine solid self-microemulsifying fast-disintegrating sublingual tablets orthogonal test evaluation quality
  • 相关文献

参考文献6

  • 1Nepal PR, Han HK, Choi HK. Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of eoenzyme Q(10)[J]. Eur J Pharm 8ci,2010,39(4): 224-232.
  • 2苏卫,陈鹰,董少华,胡晓,胡静波.尼莫地平自微乳化释药系统的研制[J].中国药师,2013,16(4):516-520. 被引量:3
  • 3刘辉,石惠婵,李强.预胶化淀粉对羟苯磺酸钙胶囊溶出度的影响[J].中国药房,2008,19(1):39-41. 被引量:2
  • 4中国药典.二部[S].2010:凡例ⅩⅦ.
  • 5Bi Y, Sunada H, Yonezawa Y,et al. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity[J]. Chem Pharm Bull (Tokyo), 1996, 44 ( 11 ): 2121- 2127.
  • 6Rawas-Qalaji MM, Simons FE, Simons KJ. Fast-disintegrating sublingual tablets:effect of epinephrine load on tablet characteristic s[J]. AAPS Pharm Sci Tech,2006,7(2):72-78.

二级参考文献7

共引文献162

同被引文献96

  • 1张晓君,王东凯,韩晓.聚合物胶束作为药物传递系统的研究进展[J].中国药剂学杂志(网络版),2009(3):177-183. 被引量:18
  • 2张春伟.卡前列甲脂栓联合米索前列腺醇舌下给药预防产后出血的效果评价[J].求医问药(下半月),2013(9):277-278. 被引量:3
  • 3包克珍,王明惠.安定溶液舌下给药治疗小儿惊厥疗效观察[J].西部医学,2006,18(5):566-567. 被引量:4
  • 4XIONG R, LU W, LI J, et al. Preparation and characterization of intravenously injectable nimodipine nanosuspension [ J ]. In- ternational Journal of Pharmaceutics, 2008, 350 ( 2 ) : 338 - 343.
  • 5KTISTIS G. FDA warns of serious harm from IV administration of nimodipine [ J ]. Reactions Weekly, 2013, 1313 ( 1 ) : 4 - 5.
  • 6KARAVAS E, KTISTIS G, XENAKIS A, et al. Effect of hydro- gen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone [ J ]. European Journal of Pharmaceutics and Biopharmaceutics, 2006, 63 ( 2 ) : 103 - 114.
  • 7ANNA K, BARTOMIEJ M, KACPER D, et al. Mesoporous drug carrier systems for enhanced delivery rate of poorly water - soluble drug: nimodipine. Journal of Porous Materials, 2015, 22 (3) : 817 -829.
  • 8ZHENG X, YANG R, TANG X, et al. Part I : characterization of solid dispersions of nimodipine prepared by hot - melt extru- sion [ J ]. DrugDevelopment and Industrial Pharmacy, 2007, 33 : 791 - 802.
  • 9MULLER R H, RADTKE M, WISSING S A. Nanostructured lipid matrices for improved microencapsulation of drugs [ J ]. International Journal of Pharrnaceutics, 2002, 242 ( 1 - 2 ) : 121 - 128.
  • 10NEPAL P R, HAN H K, CHOI H K. Preparation and invitro - in vivo evaluation of witepsol H35 based self - nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q (10) [ J ]. European Journal of Pharmaceutical Sciences, 2010, 39 (4) : 224 - 232.

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部